Zusammenfassung
Die Risiken, die mit der Transfusion von Blut und Blutderivaten verbunden sind, werden häufig unterschätzt. Komplikationen treten etwa bei 2-3% aller Bluttransfusionen auf (Mollison et al. 1987; Walker 1987; Schricker 1988). Diese Komplikationen werden durch immunologische, infektiöse und metabolische Reaktionen verursacht. Ein Risiko in bezug auf metabolische Komplikationen besteht v. a. bei der raschen Infusion großer Mengen an Blutkomponenten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Alter MJ (1994) Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch Pathol Lab Med 118(4): 342–345
ASA Task Force (1996) Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84: 732–747
Azzi A, Morfini M, Mannuci PM (1999) The transfusion-associated transmission of Parvovirus B19. Tansfusion Medicine Reviews 13: 194–204
BÄK Bundesärztekammer (1996) Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Deutscher Ärzteverlag, Köln
Beutler F (1977) International forum: What is the clinical importance of the hemoglobin oxygen affinity in preserved blood especially as produced by variations of red cell 2,3 DPG content? Vox Sang 4: 1
Bishop JF, Schiffer CA, Aisner J, Matthews JP, Wiernik PH (1987) Surgery in acute leukemia: a review of 167 operations in thromboerytopenic patients. Ann J Hematol 26: 147–155
Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP (1993) Allogeneic blood transfusion in enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 81: 1880–1882
Blajchman MA (1998) Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang 74 [Suppl 2]: 155–159
Blumberg N, Heal JM (1996) Immunomodelation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 101: 299–308
Bordin JO, Badossy L, Blajchman MA (1994) Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and ist amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 84: 344–348
Bowden RA, Slichter SJ, Sayers M et al. (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after bone marrow transplant. Blood 86: 3598–3603
Brecker ME (1996) Hemolytic transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA (eds) Principles of transfusion medicine. Williams & Wilkins, Baltimore Philadelphia London, pp 747–763
Carson JL, Duff A, Poses RM et al. (1996) Effect of anemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348: 1055–1060
Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, O’Hara DA, Noveck H, Strom BL (1998) Perioperative blood transfusion and postoperative mortality. JAMA 279: 199–205
Chen AY, Carson JL (1998) Perioperative management of anaemia. Br J Anaesth 81(Suppl.1): 20–24
Cohen D, Weinstein H, Mihm M, Yankee R (1979) Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors. Blood 53: 1053–1057
Collins JA, Högman CF, Lundsgaard-Hansen P, Snyder E, Swank RL, Wenz B (1986) When is microfiltration of whole blood and red cell concentrates essential? When is it superfluous? International Forum. Vox Sang 45: 217
Crosson JT (1996) Massive transfusion. Clin Lab Med 16: 873–882
Denlinger JK, Nahrwold ML, Gibbs PS (1976) Hypocalcaemia during rapid blood transfusion in anaesthesized man. Br J Anaest 48: 995–1000
Dinsmore RE, Straus Dj, PoFlack MS et al. (1980) Fatal graft-versus-host disease following blood transfusion in Hodgkin’s disease documented by HLA-typing. Blood 55: 831–834
Dodd RY (1998) Transmission of parasites by blood transfusion. Vox Sang 74 [Suppl 2]: 161–163
Doughty HA, Murphy MF, Metcalfe P, et al. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 66: 200–205
Fang WC, Helm RE, Krieger KH, Rosengart TK, Du-Bois WJ, Sason C, Lesser ML, Isom OW, Gold JP (1997) Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96: 2–9
Fehr J, Hofmann V, Kappeier U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma-globulin. N Engl J Med 306: 1254–1258
Fliedner V von, Higby DJ, Kim U (1982) Graft-versus-host reaction following blood product transfusion. Am J Med 72: 951–961
Ford JM, Cullen MH, Lucey JJ, Tobias JS, Lister TA (1976) Fatal graft-versus-host disease following transfusion of granulocytes from normal donors. Lancet 2: 1167–1169
Gärtner BC, Mueller-Lantzsch N (1999) Virologische Aspekte zur Sicherheit von Blutprodukten. Anästhesiol Intensivmed Notfallmed Schmerzther 34: 486–488
Glück D, Kubanek B, Maurer C, Petersen N (1998) Seroconversion of HIV, HCV and HBV in blood donors in 1996—risk of virustransmission by blood products in Germany. Infusionsther Transfusionsmed 35: 82–84
Gold MS, Dietz PA, Heneghan SJ, MacMillan RW, Moglia RM, Rudnicki M (1996) Emergency surgery in hematologic patients. World J Surg 20: 1133–1140
Goldman M, Blajchman MA (1991) Blood-productassociated bacterial sepsis. Transfus Med Rev 5: 73–83
Guyton AC, Richardson TQ (1961) Effect of hematocrit on venous return. Circ Res 9: 157–164
Hamblin TJ, Naorose Abidi SM, Nee PA, Copplestone A, Mufti GJ, Oscier DG (1985) Successful treatment of post-transfusion purpura with high dose immunoglobulins after lack of response to plasma exchange. Vox Sang 49: 164–167
Hardy JF, Martineau R, Couturier A, Belisle S, Cartier R, Carrier M (1998) Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth 81 [Suppl 1]: 38–45
Heber PC for the Transfusion Requirements in Critical Care Investigators and Canadian Critical Care Trials Group (1998) Transfusion requirements in critical care (TRICC): a multicenter, randomized, controlled clinical study. Br J Anaesth 81 [Suppl. 1]: 25–33
Heber PC, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409–417
Heddle NM (1999) Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 6: 420–426
Heiss MM, Mempel W, Jauch KE et al. (1993) Beneficial effect of autologous blood transfusion on infection complications after colorectal cancer surgery. Lancet 342: 1328–1333
Heiss MM (1998) Risk of allogeneic transfusion. Br J Anaesth 81: 16–19
Higby DJ, Burnett D (1980) Granulocyte transfusions: current status. Blood 55: 2–8
Hitzler W (1993) The present status of blood filtration —fundamentals and the clinical significance of leukocyte depletion and microaggregate filters in blood transfusion. Anästhesiol Intensivmed Notfallmed Schmerzther 28: 341–351
Hocker P, Hartmann T (1997) Management of massive transfusion. Acta Anaesthesiol Scand [Suppl.]: 205–207
Hogue-CW J, Goodnough LT, Monk TG (1998) Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 38: 924–931
Honig CL, Bove JR (1980) Transfusion-associated fatalities: Review of Bureau of Biologies reports 1976-1978. Transfusion 20: 653–661
Houbiers JG, Brand A, van de Watering LM et al. (1994) Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coatdepleted blood in surgery for colorectal cancer. Lancet 344: 573–578
Houbiers JG, van de Velde CJ, van de Watering LM, et al. (1997) Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 37: 1126–1234
Howland WS (1978) Calcium, potassium and pH changes during massive transfusion. In: Nusbacher J (ed) Massive transfusion. Symposium of the Am. Assoc. Blood Banks, Washington/D.C.
Humpe A, Heermann K-H, Köhler M (1999) Infektionen mit Hepatitis-C-Virus durch Quarantäneplasma. Dtsch Ärztebl 96: A2749-2753
Imbach P, Barandus S, d’Appuzzo V et al. (1981) High-dose intravenous gammaglubolin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228–1230
Jacob HAS, Craddock PR, Hammerschmidt DE, Moldow CF (1980) Complement-induced granulocyte aggregation. An unsuspected mechanismof disease. N Engl J Med 302: 789–794
Jensen LS, Andersen AJ, Christiansen PM et al. (1992) Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 79: 513–516
Kapadia F, Valentine S, Smith G (1992) The role of blood microfilters in clinical practice. Intens Care Med 18: 258–263
Karp DD, Ervin DJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ (1982) Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang 42: 57–61
Kernoff PB, Durrant IJ, Rizza CR, Wright FW (1972) Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 23: 777–781
Kirmani S, Geier LJ, Gandara DR (1983) Posttransfusion purpura and isoimmune neonatal thrombocytopenia in the same family. A case report (Abstract). Blood 62 [Suppl. 1]: 245a
Klein HG (1999) Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 91: 861–865
Klose R (1984) Problematik der akuten Blutung in der Anaesthesie. In: Gerinnungsprobleme in der Intensivmedizin. Gerinnungssymposium der Behringwerke anläßlich des Zentraleuropäischen Anaesthesiekongresses 13.-17.09.1983. Behring, Marburg
Klose R, Czaika A, Müller A (1981) Bildung von Mikroaggregation in buffycoat-freien Erythrozytenkonzentraten. Anaesthestist 30: 415–420
Kopko PM, Holland PV (1999) Transfusion-related acute lung injury. Br J Hematol 105: 322–329
Kretschmer V, Weipert-Kretschmer M, Karger R (1997) Notfall-und Massivtransfusion. Infusionsther Transfusionsmed 24: 106–113
Kroll H, Kiefel V, Mueller-Eckhardt C(1993) Poststransfusionspurpura: Klinische und immunologische Untersuchungen bei 38 Patienten. Infusionsther Transfusionsmed 20: 198–204
Landesberg G, Luria MH, Cotev S, Eidelman LA, Anner H, Mosseri M, Schechter D, Assaf J, Erel J, Berlatzky Y (1993) Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341: 715–719
Linden JV (1999) Errors in transfusion medicine — scope of the problem. Arch Pathol Lab Med 123: 563–565
Linden JV, Paul B, Dressler KP (1992) A report of 104 transfusion errors in New York State. Transfusion 32: 601–606
Lorentz A, Gasteiger P, Osswald PM (1987) Berechnung des zulässigen Blutverlustes mit einem programmierbaren Taschenrechner. Anaesthesist 36: 306–312. Erratum: Anaesthesist 37: 396
Lunsgaard-Hansen P (1980) Component therapy of surgical hemorrhage. Bibl Haematol 46: 147–169
McClelland B (1998) Perioperative red cell transfusion: evidence, guidelines and practice. Vox Sang 74 [Suppl 2]: 3–10
Messmer K (1975) Hemodilution. Surg Clin North Am 55: 659–678
MMWR (1999) Transfusion-transmitted malaria — Missouri and Pennsylania, 1996-1998. MMWR Morb Mortal Wkly Rep 48: 253–256
Mollison PL, Engelfriet CP, Contreras M (1987) Blood transfusion in clinical medicine. Black-well, Oxford
Moor AC, Dubbelman TM, VanSteveninck J, Brand A (1999) Transfusion-transmitted diseases: risk, prevention and perspectives. Eur J Haematol 62: 1–18
Müller C (1999) The hepatitis alphabet—Hepatits A-G and TTV. Wien Klin Wochenschr 111: 461–468
Müller-Eckhardt C (1986) Poststransfusion purpura. Br J Hematol 64: 419–424
Nelson AH, Fleisher LA, Rosenbaum SH (1993) Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 21: 860–866
Ohto H, Anderson KC (1999) Survey of transfusionassociated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 10: 31–43
Orlin JB, Ellis MH (1997) Transfusion-associated graft-versus-host disease. Curr Opin Hematol 4: 442–448
Petrány GG, Réti M, Harsányi V, Szabo J (1997) Immunologic consequences of blood transfusion and their clinical manifestations. Int Arch Allergy Immunol 114: 303–315
Popovsky MA, Moore SB (1985) Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 25: 573–577
Popovsky MA, Chaplin HC, Moore SB (1992) Transfusion-related acute lung injury — a neglected serious complication of hemotherapy. Transfusion 32: 581–592
Rachel JM, Summers TC, Sinor LT, Plapp FV (1988) Use of a solid-phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 90: 63–68
Redman M, Regan F, Contreras M (1996) a prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 71: 216–220
Roelck D (1996) Nichtinfektiöse unerwünschte Nebenwirkungen. In: Müller-Eckard C (Hrsg) Transfusionsmedizin. Springer, Berlin Heidelberg New York Tokyo, pp 525–548
Rosario MD, Rumsey EW, Arakaki G, Tanoue RE, McDanal J, McNamara JJ (1978) J Trauma 18: 498–506
Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 2: 193–195
Sazama K (1985) Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 30: 583–590
Schmidmeier W, Feil W, Gebhard W et al. (1982) Fatal graf-versus-host reaction following granulocyte transfusions. Blut 45: 115–119
Schmitt HJ, Götz E (1988) Metabolic disorders caused by blood transfusions. Infusionstherapie 15: 254–260
Schricker KT (1988) Der Transfusionszwischenfall. Anaesth Intensivmed 29: 37–41
Sheldon GF (1977) International forum: What is the clinical importance of alterations of the hemoglobine oxygen affinity in preserved blood espescially as produced by variations of red cell 2,3-DPG content? Vox Sang 4: 1
Sherwood WC (1993) The significance of the bloodborne viruses: blood banking and transfusion medicine. Dev Biol Stand 81: 25–33
Silver H, Tahhan HR, Anderson J, Lachman M (1992) A non-computer-dependent prospective review of blood and blood component utilization. Transfusion 32: 260–265
Simmonds P (1998) Transfusion virology: progress and challenges. Blood Reviews 12: 171–177
Spahn DR, Leone BJ, Reves JG, Pasch T (1994) Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 78: 1000–1021
Spiess BD, Ley C, Body SC, Spiegel LC, Stover EP, Maddi R, D’Ambra M, Jain U, Liu F, Herskowitz A, Mangano DT, Levin J (1998) Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovascu Surg 116: 460–467
Spilker D, Kilian J (1987) Der hämorrhagisch-traumatische Schock. In: Kilian J, Messmer K, Ahnefeld FW (Hrsg) Schock. Springer, Berlin Heidelberg New York Tokyo, S 101–117
Stephen CR, Martin RC, Bourgeois-Gavardin M (1955) Antihistaminic drugs in treatment of nonhemolytic transfusion reactions. JAMA 158: 525–529
Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, D’Ambra MN, Mangano DT, Spiess BD (1998) Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 88: 327–333
Sugg U (1986) Zum Problem der posttransfusionellen Hepatitis. Beitr Infusionsther Klin Ernähr 15: 30
Sugg U (1987) Die Risiken der Transfusion von Blut und Blutderivaten. Anästhesiol Intensivmed 28: 343–346
Tabor E (1982) Transfusion transmitted infections. In: Tabor E (ed) Infectious complications of blood transfusion. Academic Press, New York London, pp 87–92
Thaler M, Shamiss A, Orgad S et al. (1989) The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 321: 25–28
Thomas R, Hessel E, Harker LA, Sands MP, Dillard DH (1981) Platelet function during and after deep surface hypothermia. J Surg Res 31:314–318
TRAP Trial Study Group (1997) A randomized trial evaluating leucocyte reduction an UV-B irradiation of platelets to prevent alloimmune platelet refractoriness. N Engl J Med 337: 1861–1869
Vamvakis EC (1995) Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 34: 760–768
Vamvakis EC (1996) Transfusion-associated cancer recurrence and postoperative infection: metaanalysis of randomized, controlled trials. Transfusion 36: 175–186
Vyas GN, Holmdahl L, Perkins HA, Fudenberg HH (1969) Serological specifity of human anti-IgA and its significance in transfusion. Blood 34: 573–581
Walker RH (1987) Special report: transfusion risks. Am J Clin Pathol 88: 374
Weber JG, Warner MA, Moore SB (1995) What is the incidence of perioperative transfusion-related acute lung injury? Anesthesiology 82: 189
Weiden PL, Zuckerman N, Hansen JA, Sale GE, Remlinger K, Beck TM, Buckner CD (1981) Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusions. Blood 57: 328–332
Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA (1998) Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279: 217–221
Wilkinson SL, Shoos Lipton K (1999) Leukocyte reduction. Association Bulletin, AABB 99-7: 17–23
Williamson LM, Warwick RM (1999) Transfusionassociated graft-versus-host disease and ist prevention. Blood Rev 9: 251–261
Woods WG, Lubin BH (1981) Fatal graft-versus-host disease following a blood transfusion in a child with neuroblastoma. Pediatrics 67: 217–221
McCollough J (1998) Complications of transfusion. In: McCullough J (ed) Transfusion medicine. McGraw-Hill, New York St. Louis San Francisco, pp 337–359
McCollough J (1998) Transfusion-transmitted diseases. In: McCullough J (ed) Transfusion medicine. McGraw-Hill, New York St. Louis San Francisco, pp 361–386
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lorentz, A., Gombotz, H. (2003). Postoperative Übelkeit und Erbrechen (PONV). In: List, W., Osswald, P., Hornke, I. (eds) Komplikationen und Gefahren in der Anästhesie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55858-0_45
Download citation
DOI: https://doi.org/10.1007/978-3-642-55858-0_45
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66433-8
Online ISBN: 978-3-642-55858-0
eBook Packages: Springer Book Archive